FDA approval is still pending for a new diabetes drug called Galvus that's supposed to help the body balance sugar and insulin production. If approved, it will be the second in a new class of drugs -- with the first being Januvia -- approved in the U.S. last October. In this week's 'Dealing with Diabetes' segment, we take a closer look at what sets the new class apart from the rest.
The drug Januvia prevents the breakdown of GLP-1, a hormone that raises insulin production. It also indirectly inhibits the increase of blood-sugar levels. The once-a-day tablet is the first in a new class of drugs -- called DPP-4 inhibitors. Las Vegas endocrinologist, Fred Toffel, says it's especially ideal for treating an early onset of diabetes.
Dr. Toffel says, "Where it's best useful is early in the disease, people who are close to goal, where you just want to get them a bit lower and get lower safely. That's really where I see this niche. And that's a big niche."
With DPP-4 inhibitors, if blood sugar levels are normal, it doesn't do anything at all -- thereby reducing the risk of hypoglycemia or low sugar. Dr. Toffel says it's a safe drug that can be used alone or in combination. But unlike its well-known injectable counterpart, Byetta, Januvia does not appear to promote weight loss.
Dr. Toffel says, "It's not going to help you loose weight, but it's not going to have you gain weight. Also, essentially, very little side-effects."
Newer drugs are often more expensive and this is the case with Januvia. So depending on your coverage, it may or may not be affordable.
Dr. Toffel says,"The most cost-effective medicine for people are medically poor or have type-2 diabetes is diet and exercise. You get that for nothing. And it's by far still the number one treatment for type-2 disease."
Januvia is made by Merck Pharmaceuticals. It's expected to be a major boost for the drug company, after having to scrap their popular osteoarthritis drug, Vioxx.
Wednesday, June 19 2013 7:06 PM EDT2013-06-19 23:06:17 GMT
LAS VEGAS -- Obesity is an epidemic that's plagued our nation for decades. The American Medical Association now labels obesity a disease. There are 78 million obese adults and 12 million obese children. ElectedMore>>
Elected officials are trying to combat the obesity crisis in Las Vegas. On Wednesday, the Las Vegas City Council passed a resolution that increases access to healthy food options in under served areas.More>>
Tuesday, June 4 2013 12:58 PM EDT2013-06-04 16:58:12 GMT
TUESDAY, June 4 (HealthDay News) -- Compared to nonsmoking employees, every staff member who lights up costs their employer nearly $6,000 more each year, according to a new report. The researchers foundMore>>
Compared to nonsmoking employees, every staff member who lights up costs their employer nearly $6,000 more each year, according to a new report.More>>
Thursday, May 2 2013 6:25 PM EDT2013-05-02 22:25:44 GMT
We usually think of women when we talk about breast cancer, but men are affected as wellin fact about 2-thousand men in this country country are diagnosed with breast cancer everyone, and about 400 die from the disease.More>>
Most discussions about breast cancer tend to focus on women, but men are also affected by the disease. Every year, nearly 2,000 men in this country are diagnosed with breast cancer.More>>